Lucid Diagnostics Q1 2024 Adj EPS $(0.21) Beats $(0.27) Estimate, Sales $1.001M Miss $1.046M Estimate
Lucid Diagnostics Q1 2024 Adj EPS $(0.21) Beats $(0.27) Estimate, Sales $1.001M Miss $1.046M Estimate
Lucid Diagnostics 2024年第一季度調整後每股收益美元（0.21）超過預期（0.27）美元，銷售額爲10.46萬美元的預期
Lucid Diagnostics (NASDAQ:LUCD) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.27) by 22.22 percent. This is a 12.5 percent increase over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $1.001 million which missed the analyst consensus estimate of $1.046 million by 4.33 percent. This is a 124.44 percent increase over sales of $446.000 thousand the same period last year.
Lucid Diagnostics（納斯達克股票代碼：LUCD）公佈的季度虧損爲每股0.21美元，比分析師普遍預期的0.27美元（0.27美元）高出22.22％。這比去年同期每股虧損0.24美元（0.24美元）增長了12.5％。該公司公佈的季度銷售額爲10.1萬美元，比分析師普遍預期的10.46億美元低4.33％。這比去年同期的44.6萬美元銷售額增長了124.44％。